Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAcumen Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.51 | -$0.47 | -$0.49 |
| Q2 2025 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q3 2025 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q4 2025 | 1 | -$0.52 | -$0.52 | -$0.52 |
Acumen Pharmaceuticals, Inc. Earnings Date And Information
Acumen Pharmaceuticals, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.5 earnings per share for the quarter, missing analysts' consensus estimates of $-0.36 by $0.14. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Acumen Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-1.08 diluted earnings per share) and currently has a price-to-earnings ratio of -1.21. Acumen Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based on prior year's report dates.
Acumen Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.36 | -$0.50 | -0.14 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$0.28 | -$0.34 | -0.06 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.23 | -$0.25 | -0.02 | $0 | |
| 03/26/2024 | Q4 2023 | -$0.29 | -$0.28 | 0.01 | $290,000 | |
| 11/13/2023 | Q3 2023 | -$0.31 | -$0.24 | 0.07 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.36 | -$0.28 | 0.08 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.33 | -$0.23 | 0.1 | $0 | |
| 03/27/2023 | Q4 2022 | -$0.28 | -$0.34 | -0.06 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.27 | -$0.25 | 0.02 | $0 | |
| 08/15/2022 | Q2 2022 | -$0.24 | -$0.24 | 0 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.17 | -$0.22 | -0.05 | $0 | |
| 03/28/2022 | Q4 2021 | -$0.14 | -$0.22 | -0.08 | $0 | |
| 11/15/2021 | Q3 2021 | -$0.21 | -$0.10 | 0.11 | $0 | |
| 08/16/2021 | Q2 2021 | -$4.56 | -$1.59 | 2.97 | $0 | |
| 03/30/2021 | Q1 2021 | -$0.73 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.03 | $1.44 M | |||
| 09/29/2020 | Q3 2020 | -$0.09 | $730,000 | |||
| 06/29/2020 | Q2 2020 | -$0.07 | $151,000 | |||
| 03/30/2020 | Q1 2020 | -$0.07 | $226,000 |
Acumen Pharmaceuticals, Inc. Earnings: FAQ's
When is Acumen Pharmaceuticals, Inc.'s earnings date?
Acumen Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based off last year's report dates.
How can I listen to Acumen Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for Acumen Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read Acumen Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Acumen Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much profit does Acumen Pharmaceuticals, Inc. generate each year?
Acumen Pharmaceuticals, Inc. (:ABOS) has a recorded net income of $0. Acumen Pharmaceuticals, Inc. has generated $-1.08 earnings per share over the last four quarters.
What is Acumen Pharmaceuticals, Inc.'s price-to-earnings ratio?
Acumen Pharmaceuticals, Inc. (:ABOS) has a price-to-earnings ratio of -1.21 and price/earnings-to-growth ratio is 0.05.